Cargando…
A simulated, randomized study on the safety and immunogenicity of three consecutive commercial-scale batches of the CTN-1V strain human rabies vaccine to verify the inter-batch consistency
In this study, we sought to evaluate the inter-batch consistency and safety of the CTN-1 V human rabies vaccine (Vero cells). A total of 594 healthy participants aged 10–60 years were enrolled from Mianzhu, Sichuan Province, and randomized into three batch groups to receive vaccination via the Essen...
Autores principales: | Zhou, Lei, Liu, Jingjing, Li, Jia, Liu, Xuecheng, Zhang, Jingwu, Nie, Fei, Chen, Jianmin, Chai, Jing, Lv, Jinchao, Wang, Minghui, Yu, Jiajie, Wu, Wenjie, Li, Yuhua, Zhang, Yuhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746391/ https://www.ncbi.nlm.nih.gov/pubmed/36409064 http://dx.doi.org/10.1080/21645515.2022.2138049 |
Ejemplares similares
-
Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine
por: Agarwal, Anurag, et al.
Publicado: (2022) -
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases
por: Van den Steen, Peter, et al.
Publicado: (2023) -
Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial
por: Sun, Dapeng, et al.
Publicado: (2023) -
Advances in the progress of monoclonal antibodies for rabies
por: Fan, Linlin, et al.
Publicado: (2022) -
Commentary on the implications of safety and efficacy studies in pediatric patients with administration of human rabies immune globulin (HRIG)?
por: Siegel, Jerry, et al.
Publicado: (2022)